Article
A novel hypergraph model for identifying and prioritizing personalized drivers in cancer.
PLoS computational biology - 1 Apr 2024
Zhang Naiqian, Ma Fubin, Guo Dong, Pang Yuxuan, Wang Chenye, Zhang Yusen, Zheng Xiaoqi, Wang Mingyi
Abstract excerpt
Cancer development is driven by an accumulation of a small number of driver genetic mutations that confer the selective growth advantage to the cell, while most passenger mutations do not contribute to tumor progression. The identification of these driver genes responsible for tumorigenesis is a crucial step in designing effective cancer treatments. Although many computational methods have been developed with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
